RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1

被引：0
|
作者：
Manns, M. P. [1 ]
Poordad, F. [2 ]
Bacon, B. R. [3 ]
Bruno, S. [4 ]
Esteban, R. [5 ]
Silva, M. [6 ]
Buti, M. [7 ]
Burroughs, M. [7 ]
Sniukiene, V. [7 ]
Boparai, N. [7 ]
Brass, C. A. [7 ]
Albrecht, J. K. [7 ]
Bronowicki, J. -P. [8 ]
机构：
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] St Louis Univ, Sch Med, St Louis, MO USA
[4] AO Fatebenefratelli & Oftalm, Milan, Italy
[5] Vall dHebron Univ Hosp, Barcelona, Spain
[6] Hosp Univ Austral, Pilar, Argentina
[7] Merck, Whitehouse Stn, NJ USA
[8] Univ Henri Poincare Nancy, Vandoeuvre Les Nancy, France
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60450-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
448
引用
收藏
页码：S182 / S183
页数：2
相关论文
共 50 条
  • [21] Cost-utility-analysis of peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin as initial therapy for Chinese naive patients with chronic hepatitis C
    Tarn, YH
    Lin, WA
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A46 - A46
  • [22] EFFECT OF BASELINE VIRAL LOAD (VL) ON RESPONSE TO BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN (PR) IN PATIENTS INFECTED WITH HCV GENOTYPE 1
    Gordon, Stuart C.
    Reddy, K. Rajender
    McCone, Jonathan
    Jacobson, Ira M.
    Esteban, Rafael
    Pedicone, Lisa
    Shen, Junwu
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Lawitz, Eric
    [J]. HEPATOLOGY, 2011, 54 : 812A - 812A
  • [23] Virological escape in HCV genotype-1-infected patients receiving daclatasvir plus ribavirin and peginterferon alfa-2a or alfa-2b
    McPhee, Fiona
    Hernandez, Dennis
    Zhou, Nannan
    Yu, Fei
    Ueland, Joseph
    Monikowski, Aaron
    Chayama, Kazuaki
    Toyota, Joji
    Izumi, Namiki
    Yokosuka, Osamu
    Kawada, Norifumi
    Osaki, Yukio
    Hughes, Eric A.
    Watanabe, Hideaki
    Ishikawa, Hiroki
    Kumada, Hiromitsu
    [J]. ANTIVIRAL THERAPY, 2014, 19 (05) : 479 - 490
  • [24] Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C:: a randomized controlled trial
    Bruno, S
    Cammà, C
    Di Marco, V
    Rumi, M
    Vinci, M
    Camozzi, M
    Rebucci, C
    Di Bona, D
    Colombo, M
    Craxì, A
    Mondelli, MU
    Pinzello, G
    [J]. JOURNAL OF HEPATOLOGY, 2004, 41 (03) : 474 - 481
  • [25] AN EVALUATION OF NEUTROPENIA IN THE PIVOTAL STUDIES OF BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN (PR)
    Reddy, K. Rajender
    Nunes, Frederick
    Balart, Luis A.
    Sjogren, Robert
    Pedicone, Lisa
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Sulkowski, Mark S.
    [J]. HEPATOLOGY, 2011, 54 : 814A - 814A
  • [26] Predictors of sustained virologic response among genotype 1 previous non-responders and relapsers to peginterferon/ribavirin when re-treated with boceprevir plus peginterferon alfa-2b/ribavirin
    Bognar, F.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 95 - 95
  • [27] Predictors of Sustained Virologic Response Among Genotype 1 Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin
    Zeuzem, Stefan
    Vierling, John M.
    Esteban, Rafael
    Gibas, Alexandra L.
    Pol, Stanislas
    Boparai, Navdeep
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Poordad, Fred
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S908 - S909
  • [28] PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
    Zeuzem, S.
    Vierling, J. M.
    Esteban, R.
    Gibas, A. L.
    Pol, S.
    Boparai, N.
    Burroughs, M.
    Brass, C. A.
    Albrecht, J. K.
    Poordad, F.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S198 - S199
  • [29] Predictors of sustained virologic response among genotype 1 previous non-responders and relapsers to peginterferon/ribavirin when re-treated with boceprevir plus peginterferon alfa-2b/ribavirin
    Bognar, F.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 20 - 20
  • [30] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
    McHutchison, John G.
    Lawitz, Eric J.
    Shiffman, Mitchell L.
    Muir, Andrew J.
    Galler, Greg W.
    McCone, Jonathan
    Nyberg, Lisa M.
    Lee, William M.
    Ghalib, Reem H.
    Schiff, Eugene R.
    Galati, Joseph S.
    Bacon, Bruce R.
    Davis, Mitchell N.
    Mukhopadhyay, Pabak
    Koury, Kenneth
    Noviello, Stephanie
    Pedicone, Lisa D.
    Brass, Clifford A.
    Albrecht, Janice K.
    Sulkowski, Mark S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (06): : 580 - 593
12345